Effect of intracameral acetylcholine on latanoprost in preventing ocular hypertension after phacoemulsification and intraocular lens implantation

Journal of Cataract and Refractive Surgery

Volumn 27, Issue 5, 2001, Pages 700-705

  Lai, Jimmy S M ^a   Chua, John K H ^b   Loo, Angela ^b   Ho, S Y ^a   Lam, Dennis S C ^b  

^a UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; LATANOPROST; MIOCHOL E;

ADULT; AGED; ANTERIOR EYE CHAMBER; ARTICLE; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LENS IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PHACOEMULSIFICATION; POSTERIOR EYE CHAMBER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACETYLCHOLINE; AGED; ANTIHYPERTENSIVE AGENTS; DOUBLE-BLIND METHOD; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTRAOCULAR PRESSURE; LENS IMPLANTATION, INTRAOCULAR; MALE; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PHACOEMULSIFICATION; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC;

EID: 0035008461     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0886-3350(00)00729-X     Document Type: Article

References (28)

1. Rowes J.R. Postoperative IOP in cataract surgery. (letter) Ophthalmic Surg. 20:1989;145.
2. Gross J.G., Meyer D.R., Robin Al, et al. Increased intraocular pressure in the immediate postoperative period after extracapsular cataract extraction. Am J Ophthalmol. 105:1988;466-469.
3. Kooner K.S., Cooksey J.C., Perry P., Zimmerman T.J. Intraocular pressure following ECCE, phacoemulsification, and PC-IOL implantation. Ophthalmic Surg. 19:1988;643-646.
4. Naeser K., Thim K., Hansen T.E., et al. Intraocular pressure in the first days after implantation of posterior chamber lenses with the use of sodium hyaluronate (Healon®). Acta Ophthalmol. 64:1986;330-337.
5. Mastropasqua L., Carpineto P., Ciancaglini M., Falconio G. Intraocular pressure changes after phacoemulsification and foldable silicone lens implantation using Healon GV® Ophthalmologica. 212:1998;318-321.
6. Berson F.G., Patterson M.M., Epstein D.L. Obstruction of aqueous outflow by sodium hyaluronate in enucleated human eyes. Am J Ophthalmol. 95:1983;668-672.
7. Passo M.S., Ernest J.T., Goldstick T.K. Hyaluronate increases intraocular pressure when used in cataract extraction. Br J Ophthalmol. 69:1985;572-575.
8. Fry L.L. Comparison of the postoperative intraocular pressure with Betagan, Betoptic, Timoptic, Iopidine, Diamox, Pilopine Gel, and Miostat. J Cataract Refract Surg. 18:1992;14-19.
9. Hollands R.H., Drance S.M., House P.H., Schulzer M. Control of intraocular pressure after cataract extraction. Can J Ophthalmol. 25:1990;128-132.
10. Wedrich A., Menapace A. Effect of acetylcholine on intraocular pressure following small-incision cataract surgery. Ophthalmologica. 205:1992;125-130.
11. Ruiz R.S., Rhem M.N., Prager T.C. Effects of carbachol and acetylcholine on intraocular pressure after cataract extraction. Am J Ophthalmol. 107:1989;7-10.
12. Byrd S., Singh K. Medical control of intraocular pressure after cataract surgery. J Cataract Refract Surg. 24:1998;1493-1497.
13. Obstbaum S.A., Galin M.A. The effects of timolol on cataract extraction and intraocular pressure. Am J Ophthalmol. 88:1979;1017-1019.
14. Haimann M.H., Phelps C.D. Prophylactic timolol for the prevention of high intraocular pressure after cataract extraction; a randomized, prospective, double-blind trial. Ophthalmology. 88:1981;233-238.
15. Lai J.S.M., Chua J.K.H., Leung A.T.S., Lam D.S.C. Latanoprost versus timolol gel to prevent ocular hypertension after phacoemulsification and intraocular lens implantation. J Cataract Refract Surg. 26:2000;386-391.
16. Kanellopoulos A.J., Perry H.D., Donnenfeld E.D. Timolol gel versus acetazolamide in the prophylaxis of ocular hypertension after phacoemulsification. J Cataract Refract Surg. 23:1997;1070-1074.
17. Van Buskirk E.M. Adverse reactions from timolol administration. Ophthalmology. 87:1980;447-450.
18. Nelson W.L., Fraunfelder F.T., Sills J.M., et al. Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985. Am J Ophthalmol. 102:1986;606-611.
19. 2α analog, on aqueous humor dynamics in human eyes. Ophthalmology. 100:1993;1297-1304.
20. Lindsey J.D., Kashiwagi K., Kashiwagi F., Weinreb R.N. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism implications for uveoscleral outflow . Surv Ophthalmol. 41:(suppl 2):1997;S53-S59.
21. Rácz P., Ruzsonyi M.R., Nagy Z.T., Bito L.Z. Maintained intraocular pressure reduction with once-a-day application of new prostaglandin F2α analogue (PhXA41); an in-hospital, placebo-controlled study. Arch Ophthalmol. 111:1993;657-661.
22. Alm A., Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning; a comparison with timolol. Ophthalmology. 102:1995;1743-1752.
23. Alm A., Villumsen J. PhXA34 - a new potent ocular hypotensive drug; a study on dose-response relationship and on aqueous humor dynamics in healthy volunteers. Arch Ophthalmol. 109:1991;1564-1568.
24. 2α analogue. Effect on intraocular pressure in patients with ocular hypertension. Br J Ophthalmol. 76:1992;214-217.
25. Hollands R.H., Drance S.M., Schulzer M. The effect of acetylcholine on early postoperative intraocular pressure. Am J Ophthalmol. 103:1987;749-753.
26. 2α. Arch Ophthalmol. 105:1987;1112-1116.
27. Lindén C., Alm A. Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes. Arch Ophthalmol. 115:1997;857-861.
28. Patelska B., Greenfield D.S., Liebmann J.M., et al. Latanoprost for uncontrolled glaucoma in a compassionate case protocol. Am J Ophthalmol. 124:1997;279-286.